Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00414206
Status:
TERMINATED
Last Update Posted:
2010-11-23
First Post:
2006-12-19
Brief Title:
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration AMD
Sponsor:
CoMentis
Organization:
CoMentis
Study Overview
Official Title:
A Phase II Randomized Double-Masked Study Comparing the Safety and Efficacy of ATG003 in Patients With Neovascular Wet Age-Related Macular Degeneration NV-AMD
Status:
TERMINATED
Status Verified Date:
2010-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Sponsor decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase II randomized double-masked study comparing the safety and efficacy of ATG003 mecamylamine HCl 10 and 03 ophthalmic solutions to placebo in patients with neovascular wet age-related macular degeneration NV-AMD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None